Suntrust Banks’s Puma Biotechnology PBYI Stock Holding History

Suntrust Banks’s Portfolio PBYI Stock Details PBYI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-3,701	Closed	-$323K	–	1304
2017 Q2	$323K	Sell	3,701 -24,613	-87%	-$1.38M	﹤0.01%	1016
2017 Q1	$1.05M	Buy	28,314 +14,023	+98%	+$512K	0.01%	642
2016 Q4	$438K	Buy	14,291 +2,991	+26%	+$129K	﹤0.01%	1056
2016 Q3	$757K	Buy	+11,300	New	+$571K	﹤0.01%	821
2014 Q4	–	Sell	-1,254	Closed	-$298K	–	1267
2014 Q3	$298K	Buy	+1,254	New	+$258K	﹤0.01%	1167
2014 Q2	–	Sell	-12,611	Closed	-$1.31M	–	1610
2014 Q1	$1.31M	Buy	+12,611	New	+$1.48M	﹤0.01%	833

Other funds holding PBYI

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Suntrust Banks's PBYI Position: Q3 2017 in Review

Suntrust Banks sold out of Puma Biotechnology (PBYI) in Q3 2017, closing a stake of 3,701 shares — an estimated $323K sold.

Suntrust Banks first reported a position in PBYI in Q1 2014 and held it in 6 quarters. The position peaked at $1.31M in Q1 2014. 171 funds tracked by Wall St. Rank hold PBYI as of Q3 2017.

Suntrust Banks reported no remaining Puma Biotechnology position as of Q3 2017 after selling out during the quarter.
Suntrust Banks sold 3,701 Puma Biotechnology shares in Q3 2017, an estimated $323K.
Suntrust Banks first reported a position in Puma Biotechnology in Q1 2014 and held it in 6 quarters.
Suntrust Banks's Puma Biotechnology position peaked at $1.31M in Q1 2014.
171 funds tracked by Wall St. Rank held Puma Biotechnology as of Q3 2017.

Based on Suntrust Banks's 13F filing for Q3 2017, filed 14 Nov 2017.